- Home
- CLGN vs ELEV Comparison
CLGN vs ELEV Comparison
Compare CLGN & ELEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLGN
- ELEV
- Stock Information
- Founded
- CLGN 2004
- ELEV 2019
- Country
- CLGN Israel
- ELEV United States
- Employees
- CLGN N/A
- ELEV N/A
- Industry
- CLGN Industrial Specialties
- ELEV Biotechnology: Pharmaceutical Preparations
- Sector
- CLGN Health Care
- ELEV Health Care
- Exchange
- CLGN Nasdaq
- ELEV Nasdaq
- Market Cap
- CLGN 37.4M
- ELEV N/A
- IPO Year
- CLGN N/A
- ELEV 2021
- Fundamental
- Price
- CLGN $2.58
- ELEV $0.26
- Analyst Decision
- CLGN Strong Buy
- ELEV Buy
- Analyst Count
- CLGN 2
- ELEV 7
- Target Price
- CLGN $12.50
- ELEV $3.78
- AVG Volume (30 Days)
- CLGN 12.3K
- ELEV 2.1M
- Earning Date
- CLGN 03-26-2025
- ELEV 03-06-2025
- Dividend Yield
- CLGN N/A
- ELEV N/A
- EPS Growth
- CLGN N/A
- ELEV N/A
- EPS
- CLGN N/A
- ELEV N/A
- Revenue
- CLGN $515,000.00
- ELEV N/A
- Revenue This Year
- CLGN $2,474.76
- ELEV N/A
- Revenue Next Year
- CLGN $52.63
- ELEV N/A
- P/E Ratio
- CLGN N/A
- ELEV N/A
- Revenue Growth
- CLGN N/A
- ELEV N/A
- 52 Week Low
- CLGN $2.54
- ELEV $0.24
- 52 Week High
- CLGN $6.75
- ELEV $5.83
- Technical
- Relative Strength Index (RSI)
- CLGN 26.97
- ELEV 23.59
- Support Level
- CLGN $2.54
- ELEV $0.24
- Resistance Level
- CLGN $3.70
- ELEV $0.27
- Average True Range (ATR)
- CLGN 0.26
- ELEV 0.04
- MACD
- CLGN -0.04
- ELEV -0.01
- Stochastic Oscillator
- CLGN 3.45
- ELEV 5.93
Stock Price Comparison Chart: CLGN vs ELEV
About CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.